JOHNSON & JOHNSON |
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
| 12.9 EUR | -0.77% |
|
-1.53% | -5.84% |
| 07-03 | Johnson & Johnson's Rybrevant Approved by Health Canada to Treat Advanced Lung Cancer | MT |
| 07-03 | Johnson & Johnson Lung Cancer Drug Gets Health Canada Approval | DJ |
5db09ee.Jocxc3v1q6vdBf1Ty3oGeieiP1t7pMCNleU-27vBvSI.TcJcBE66_ubqb6hhv1dZD171CQ4r9Y20o7RnsvCR6WES73wHTJnT5adzng~8688842b4d9a68f00e5db568bb570ad9
